Related Experiment Video
Updated: May 10, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Probiotics: a new way to fight bacterial pulmonary infections?
Y Alexandre1, G Le Blay2, S Boisramé-Gastrin1
1Laboratoire universitaire de biodiversité et d'écologie microbienne, EA3882, faculté de médecine, université européenne de Bretagne, CHRU de la Cavale Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France.
Abstract:
Antibiotics, of which Fleming has identified the first representative, penicillin, in 1928, allowed dramatical improvement of the treatment of patients presenting with infectious diseases. However, once an antibiotic is used, resistance may develop more or less rapidly in some bacteria. It is thus necessary to develop therapeutic alternatives, such as the use of probiotics, defined by the World Health Organization (WHO) as "micro-organisms which, administered live and in adequate amounts, confer a benefit to the health of the host". The scope of these micro-organisms is broad, concerning many areas including that of infectious diseases, especially respiratory infections. We describe the rational use of probiotics in respiratory tract infections and detail the results of various clinical studies describing the use of probiotics in the management of respiratory infections such as nosocomial or community acquired pneumonia, or on specific grounds such as cystic fibrosis. The results are sometimes contradictory, but the therapeutic potential of probiotics seems promising. Implementing research to understand their mechanisms of action is critical to conduct therapeutic tests based on a specific rational for the strains to be used, the dose, as well as the chosen mode and rhythm of administration.
Insights
Probiotics show promise as an alternative to antibiotics for treating respiratory infections, offering health benefits to the host. Further research is needed to optimize their use in clinical settings.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antibiotics revolutionized infectious disease treatment but rising resistance necessitates alternatives.
- Probiotics, live microorganisms conferring host health benefits, are a potential therapeutic avenue.
- Respiratory tract infections (RTIs) represent a significant area for probiotic application.
Purpose of the Study:
- To explore the rational application of probiotics in managing respiratory tract infections.
- To review clinical study outcomes on probiotic use for various RTIs.
- To assess the therapeutic potential and challenges of probiotics in respiratory health.
Main Methods:
- Literature review of clinical studies on probiotics for RTIs.
- Analysis of probiotic efficacy in conditions like pneumonia and cystic fibrosis.
- Synthesis of evidence regarding probiotic mechanisms and administration.
Main Results:
- Clinical study results on probiotics for RTIs are varied and sometimes contradictory.
- Probiotics demonstrate potential therapeutic benefits in managing certain respiratory conditions.
- Understanding specific probiotic strain mechanisms is crucial for effective application.
Conclusions:
- Probiotics represent a promising therapeutic alternative for respiratory infections.
- Further research is essential to elucidate mechanisms and optimize probiotic strategies.
- Tailored approaches considering strain, dose, and administration are key for future clinical success.
More Related Videos
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
03:53Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Related Concept Videos
Microbiota of the Respiratory Tract
Probiotics
Microorganisms in Medicine and Therapeutics
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...